Global and China CD38 Monoclonal Antibody Drugs Market Insights, Forecast to 2027
SKU ID : QYR-19208370 | Publishing Date : 23-Sep-2021 | No. of pages : 132
Detailed TOC of Global and China CD38 Monoclonal Antibody Drugs Market Insights, Forecast to 2027
1 Study Coverage1.1 CD38 Monoclonal Antibody Drugs Product Introduction
1.2 Market by Type
1.2.1 Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Type
1.2.2 Daretuzumab
1.2.3 Isartuximab
1.2.4 Engineered Toxin Body
1.3 Market by Application
1.3.1 Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Application
1.3.2 Multiple Myeloma
1.3.3 Diffuse Large B Cell Lymphoma
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global CD38 Monoclonal Antibody Drugs Market Size, Estimates and Forecasts
2.1.1 Global CD38 Monoclonal Antibody Drugs Revenue 2016-2027
2.1.2 Global CD38 Monoclonal Antibody Drugs Sales 2016-2027
2.2 Global CD38 Monoclonal Antibody Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 CD38 Monoclonal Antibody Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global CD38 Monoclonal Antibody Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global CD38 Monoclonal Antibody Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 CD38 Monoclonal Antibody Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global CD38 Monoclonal Antibody Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global CD38 Monoclonal Antibody Drugs Revenue Forecast by Region (2022-2027)
3 Global CD38 Monoclonal Antibody Drugs Competitor Landscape by Players
3.1 Global Top CD38 Monoclonal Antibody Drugs Manufacturers by Sales
3.1.1 Global CD38 Monoclonal Antibody Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global CD38 Monoclonal Antibody Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top CD38 Monoclonal Antibody Drugs Manufacturers by Revenue
3.2.1 Key CD38 Monoclonal Antibody Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global CD38 Monoclonal Antibody Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global CD38 Monoclonal Antibody Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global CD38 Monoclonal Antibody Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by CD38 Monoclonal Antibody Drugs Revenue in 2020
3.2.6 Global CD38 Monoclonal Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global CD38 Monoclonal Antibody Drugs Price by Manufacturers
3.4 Global CD38 Monoclonal Antibody Drugs Manufacturing Base Distribution, Product Types
3.4.1 CD38 Monoclonal Antibody Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers CD38 Monoclonal Antibody Drugs Product Type
3.4.3 Date of International Manufacturers Enter into CD38 Monoclonal Antibody Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global CD38 Monoclonal Antibody Drugs Market Size by Type (2016-2021)
4.1.1 Global CD38 Monoclonal Antibody Drugs Sales by Type (2016-2021)
4.1.2 Global CD38 Monoclonal Antibody Drugs Revenue by Type (2016-2021)
4.1.3 CD38 Monoclonal Antibody Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global CD38 Monoclonal Antibody Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global CD38 Monoclonal Antibody Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global CD38 Monoclonal Antibody Drugs Revenue Forecast by Type (2022-2027)
4.2.3 CD38 Monoclonal Antibody Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global CD38 Monoclonal Antibody Drugs Market Size by Application (2016-2021)
5.1.1 Global CD38 Monoclonal Antibody Drugs Sales by Application (2016-2021)
5.1.2 Global CD38 Monoclonal Antibody Drugs Revenue by Application (2016-2021)
5.1.3 CD38 Monoclonal Antibody Drugs Price by Application (2016-2021)
5.2 CD38 Monoclonal Antibody Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global CD38 Monoclonal Antibody Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global CD38 Monoclonal Antibody Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global CD38 Monoclonal Antibody Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China CD38 Monoclonal Antibody Drugs Market Size YoY Growth 2016-2027
6.1.1 China CD38 Monoclonal Antibody Drugs Sales YoY Growth 2016-2027
6.1.2 China CD38 Monoclonal Antibody Drugs Revenue YoY Growth 2016-2027
6.1.3 China CD38 Monoclonal Antibody Drugs Market Share in Global Market 2016-2027
6.2 China CD38 Monoclonal Antibody Drugs Market Size by Players (International and Local Players)
6.2.1 China Top CD38 Monoclonal Antibody Drugs Players by Sales (2016-2021)
6.2.2 China Top CD38 Monoclonal Antibody Drugs Players by Revenue (2016-2021)
6.3 China CD38 Monoclonal Antibody Drugs Historic Market Review by Type (2016-2021)
6.3.1 China CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2016-2021)
6.3.2 China CD38 Monoclonal Antibody Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China CD38 Monoclonal Antibody Drugs Price by Type (2016-2021)
6.4 China CD38 Monoclonal Antibody Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China CD38 Monoclonal Antibody Drugs Sales Forecast by Type (2022-2027)
6.4.2 China CD38 Monoclonal Antibody Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China CD38 Monoclonal Antibody Drugs Price Forecast by Type (2022-2027)
6.5 China CD38 Monoclonal Antibody Drugs Historic Market Review by Application (2016-2021)
6.5.1 China CD38 Monoclonal Antibody Drugs Sales Market Share by Application (2016-2021)
6.5.2 China CD38 Monoclonal Antibody Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China CD38 Monoclonal Antibody Drugs Price by Application (2016-2021)
6.6 China CD38 Monoclonal Antibody Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China CD38 Monoclonal Antibody Drugs Sales Forecast by Application (2022-2027)
6.6.2 China CD38 Monoclonal Antibody Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China CD38 Monoclonal Antibody Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America CD38 Monoclonal Antibody Drugs Market Size YoY Growth 2016-2027
7.2 North America CD38 Monoclonal Antibody Drugs Market Facts & Figures by Country
7.2.1 North America CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021)
7.2.2 North America CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific CD38 Monoclonal Antibody Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific CD38 Monoclonal Antibody Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe CD38 Monoclonal Antibody Drugs Market Size YoY Growth 2016-2027
9.2 Europe CD38 Monoclonal Antibody Drugs Market Facts & Figures by Country
9.2.1 Europe CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021)
9.2.2 Europe CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America CD38 Monoclonal Antibody Drugs Market Size YoY Growth 2016-2027
10.2 Latin America CD38 Monoclonal Antibody Drugs Market Facts & Figures by Country
10.2.1 Latin America CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021)
10.2.2 Latin America CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Johnson
12.1.1 Johnson Corporation Information
12.1.2 Johnson Description and Business Overview
12.1.3 Johnson CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Johnson CD38 Monoclonal Antibody Drugs Products Offered
12.1.5 Johnson Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi CD38 Monoclonal Antibody Drugs Products Offered
12.2.5 Sanofi Recent Development
12.3 Takeda Pharmaceutical Company
12.3.1 Takeda Pharmaceutical Company Corporation Information
12.3.2 Takeda Pharmaceutical Company Description and Business Overview
12.3.3 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Products Offered
12.3.5 Takeda Pharmaceutical Company Recent Development
12.4 CASI Pharmaceutical Company
12.4.1 CASI Pharmaceutical Company Corporation Information
12.4.2 CASI Pharmaceutical Company Description and Business Overview
12.4.3 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Products Offered
12.4.5 CASI Pharmaceutical Company Recent Development
12.5 Mab Biopharma
12.5.1 Mab Biopharma Corporation Information
12.5.2 Mab Biopharma Description and Business Overview
12.5.3 Mab Biopharma CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mab Biopharma CD38 Monoclonal Antibody Drugs Products Offered
12.5.5 Mab Biopharma Recent Development
12.11 Johnson
12.11.1 Johnson Corporation Information
12.11.2 Johnson Description and Business Overview
12.11.3 Johnson CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Johnson CD38 Monoclonal Antibody Drugs Products Offered
12.11.5 Johnson Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 CD38 Monoclonal Antibody Drugs Industry Trends
13.2 CD38 Monoclonal Antibody Drugs Market Drivers
13.3 CD38 Monoclonal Antibody Drugs Market Challenges
13.4 CD38 Monoclonal Antibody Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 CD38 Monoclonal Antibody Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and China CD38 Monoclonal Antibody Drugs Market Insights, Forecast to 2027
List of TablesTable 1. Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Daretuzumab
Table 3. Major Manufacturers of Isartuximab
Table 4. Major Manufacturers of Engineered Toxin Body
Table 5. Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Application (2021-2027) & (KG)
Table 6. Global CD38 Monoclonal Antibody Drugs Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global CD38 Monoclonal Antibody Drugs Sales by Regions (2016-2021) & (KG)
Table 8. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Regions (2016-2021)
Table 9. Global CD38 Monoclonal Antibody Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global CD38 Monoclonal Antibody Drugs Sales Forecast by Region (2022-2027) & (KG)
Table 11. Global CD38 Monoclonal Antibody Drugs Sales Market Share Forecast by Region (2022-2027)
Table 12. Global CD38 Monoclonal Antibody Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global CD38 Monoclonal Antibody Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global CD38 Monoclonal Antibody Drugs Sales by Manufacturers (2016-2021) (KG)
Table 15. Global CD38 Monoclonal Antibody Drugs Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top CD38 Monoclonal Antibody Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 17. CD38 Monoclonal Antibody Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. CD38 Monoclonal Antibody Drugs Revenue Share by Manufacturers (2016-2021)
Table 19. Global CD38 Monoclonal Antibody Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global CD38 Monoclonal Antibody Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD38 Monoclonal Antibody Drugs as of 2020)
Table 21. Key Manufacturers CD38 Monoclonal Antibody Drugs Price (2016-2021) (US$/g)
Table 22. CD38 Monoclonal Antibody Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers CD38 Monoclonal Antibody Drugs Product Type
Table 24. Date of International Manufacturers Enter into CD38 Monoclonal Antibody Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global CD38 Monoclonal Antibody Drugs Sales by Type (2016-2021) (KG)
Table 27. Global CD38 Monoclonal Antibody Drugs Sales Share by Type (2016-2021)
Table 28. Global CD38 Monoclonal Antibody Drugs Revenue by Type (2016-2021) (US$ Million)
Table 29. Global CD38 Monoclonal Antibody Drugs Revenue Share by Type (2016-2021)
Table 30. CD38 Monoclonal Antibody Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/g)
Table 31. Global CD38 Monoclonal Antibody Drugs Sales Forecast by Type (2022-2027) & (KG)
Table 32. Global CD38 Monoclonal Antibody Drugs Sales Market Share Forecast by Type (2022-2027)
Table 33. Global CD38 Monoclonal Antibody Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global CD38 Monoclonal Antibody Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global CD38 Monoclonal Antibody Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/g)
Table 36. Global CD38 Monoclonal Antibody Drugs Sales by Application (2016-2021) (KG)
Table 37. Global CD38 Monoclonal Antibody Drugs Sales Share by Application (2016-2021)
Table 38. Global CD38 Monoclonal Antibody Drugs Revenue by Application (2016-2021) (US$ Million)
Table 39. Global CD38 Monoclonal Antibody Drugs Revenue Share by Application (2016-2021)
Table 40. CD38 Monoclonal Antibody Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/g)
Table 41. Global CD38 Monoclonal Antibody Drugs Sales Forecast by Application (2022-2027) & (KG)
Table 42. Global CD38 Monoclonal Antibody Drugs Sales Market Share Forecast by Application (2022-2027)
Table 43. Global CD38 Monoclonal Antibody Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global CD38 Monoclonal Antibody Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global CD38 Monoclonal Antibody Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/g)
Table 46. China CD38 Monoclonal Antibody Drugs Sales (KG) of Key Companies (2016-2021)
Table 47. China CD38 Monoclonal Antibody Drugs Sales Share by Company (2016-2021)
Table 48. China CD38 Monoclonal Antibody Drugs Revenue (US$ Million) by Company (2016-2021)
Table 49. China CD38 Monoclonal Antibody Drugs Revenue Share by Company (2016-2021)
Table 50. China CD38 Monoclonal Antibody Drugs Sales (KG) by Type (2016-2021)
Table 51. China CD38 Monoclonal Antibody Drugs Sales Share by Type (2016-2021)
Table 52. China CD38 Monoclonal Antibody Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China CD38 Monoclonal Antibody Drugs Price (US$/g) by Type (2016-2021)
Table 54. China CD38 Monoclonal Antibody Drugs Sales (KG) by Type (2022-2027)
Table 55. China CD38 Monoclonal Antibody Drugs Sales Share by Type (2022-2027)
Table 56. China CD38 Monoclonal Antibody Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China CD38 Monoclonal Antibody Drugs Revenue Share by Type (2022-2027)
Table 58. China CD38 Monoclonal Antibody Drugs Price (US$/g) by Type (2022-2027)
Table 59. China CD38 Monoclonal Antibody Drugs Sales (KG) by Application (2016-2021)
Table 60. China CD38 Monoclonal Antibody Drugs Sales Share by Application (2016-2021)
Table 61. China CD38 Monoclonal Antibody Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China CD38 Monoclonal Antibody Drugs Price (US$/g) by Application (2016-2021)
Table 63. China CD38 Monoclonal Antibody Drugs Sales (KG) by Application (2022-2027)
Table 64. China CD38 Monoclonal Antibody Drugs Sales Share by Application (2022-2027)
Table 65. China CD38 Monoclonal Antibody Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China CD38 Monoclonal Antibody Drugs Revenue Share by Application (2022-2027)
Table 67. China CD38 Monoclonal Antibody Drugs Price (US$/g) by Application (2022-2027)
Table 68. North America CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021) & (KG)
Table 69. North America CD38 Monoclonal Antibody Drugs Sales Market Share by Country (2016-2021)
Table 70. North America CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America CD38 Monoclonal Antibody Drugs Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Region (2016-2021) & (KG)
Table 73. Asia Pacific CD38 Monoclonal Antibody Drugs Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue Market Share by Region (2016-2021)
Table 76. Europe CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021) & (KG)
Table 77. Europe CD38 Monoclonal Antibody Drugs Sales Market Share by Country (2016-2021)
Table 78. Europe CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe CD38 Monoclonal Antibody Drugs Revenue Market Share by Country (2016-2021)
Table 80. Latin America CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021) & (KG)
Table 81. Latin America CD38 Monoclonal Antibody Drugs Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America CD38 Monoclonal Antibody Drugs Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021) & (KG)
Table 85. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue Market Share by Country (2016-2021)
Table 88. Johnson Corporation Information
Table 89. Johnson Description and Business Overview
Table 90. Johnson CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 91. Johnson CD38 Monoclonal Antibody Drugs Product
Table 92. Johnson Recent Development
Table 93. Sanofi Corporation Information
Table 94. Sanofi Description and Business Overview
Table 95. Sanofi CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 96. Sanofi Product
Table 97. Sanofi Recent Development
Table 98. Takeda Pharmaceutical Company Corporation Information
Table 99. Takeda Pharmaceutical Company Description and Business Overview
Table 100. Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 101. Takeda Pharmaceutical Company Product
Table 102. Takeda Pharmaceutical Company Recent Development
Table 103. CASI Pharmaceutical Company Corporation Information
Table 104. CASI Pharmaceutical Company Description and Business Overview
Table 105. CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 106. CASI Pharmaceutical Company Product
Table 107. CASI Pharmaceutical Company Recent Development
Table 108. Mab Biopharma Corporation Information
Table 109. Mab Biopharma Description and Business Overview
Table 110. Mab Biopharma CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 111. Mab Biopharma Product
Table 112. Mab Biopharma Recent Development
Table 113. CD38 Monoclonal Antibody Drugs Market Trends
Table 114. CD38 Monoclonal Antibody Drugs Market Drivers
Table 115. CD38 Monoclonal Antibody Drugs Market Challenges
Table 116. CD38 Monoclonal Antibody Drugs Market Restraints
Table 117. CD38 Monoclonal Antibody Drugs Customers List
Table 118. CD38 Monoclonal Antibody Drugs Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. CD38 Monoclonal Antibody Drugs Product Picture
Figure 2. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Daretuzumab Product Picture
Figure 4. Isartuximab Product Picture
Figure 5. Engineered Toxin Body Product Picture
Figure 6. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Application in 2020 & 2027
Figure 7. Multiple Myeloma
Figure 8. Diffuse Large B Cell Lymphoma
Figure 9. Other
Figure 10. CD38 Monoclonal Antibody Drugs Report Years Considered
Figure 11. Global CD38 Monoclonal Antibody Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global CD38 Monoclonal Antibody Drugs Market Size 2016-2027 (US$ Million)
Figure 13. Global CD38 Monoclonal Antibody Drugs Sales 2016-2027 (KG)
Figure 14. Global CD38 Monoclonal Antibody Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Region (2016-2021)
Figure 16. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Region in 2020
Figure 17. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Region (2016-2021)
Figure 18. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Region in 2020
Figure 19. Global CD38 Monoclonal Antibody Drugs Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by CD38 Monoclonal Antibody Drugs Revenue in 2020
Figure 21. CD38 Monoclonal Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2016-2021)
Figure 23. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Type in 2020
Figure 24. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Type (2016-2021)
Figure 25. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Type in 2020
Figure 26. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Application (2016-2021)
Figure 27. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Application in 2020
Figure 28. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Application (2016-2021)
Figure 29. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Application in 2020
Figure 30. China CD38 Monoclonal Antibody Drugs Sales Growth Rate 2016-2027 (KG)
Figure 31. China CD38 Monoclonal Antibody Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China CD38 Monoclonal Antibody Drugs Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest CD38 Monoclonal Antibody Drugs Players Market Share by Revenue in CD38 Monoclonal Antibody Drugs in 2020
Figure 34. China CD38 Monoclonal Antibody Drugs Revenue Share by Type (2016-2021)
Figure 35. China CD38 Monoclonal Antibody Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China CD38 Monoclonal Antibody Drugs Revenue Share by Application (2016-2021)
Figure 37. China CD38 Monoclonal Antibody Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America CD38 Monoclonal Antibody Drugs Sales Growth Rate 2016-2021 (KG)
Figure 39. North America CD38 Monoclonal Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America CD38 Monoclonal Antibody Drugs Sales Market Share by Country in 2020
Figure 41. North America CD38 Monoclonal Antibody Drugs Revenue Market Share by Country in 2020
Figure 42. United States CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 43. United States CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 45. Canada CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe CD38 Monoclonal Antibody Drugs Sales Growth Rate 2016-2021 (KG)
Figure 47. Europe CD38 Monoclonal Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe CD38 Monoclonal Antibody Drugs Sales Market Share by Country in 2020
Figure 49. Europe CD38 Monoclonal Antibody Drugs Revenue Market Share by Country in 2020
Figure 50. Germany CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 51. Germany CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 53. France CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 55. U.K. CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 57. Italy CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 59. Russia CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific CD38 Monoclonal Antibody Drugs Sales Growth Rate 2016-2021 (KG)
Figure 61. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific CD38 Monoclonal Antibody Drugs Sales Market Share by Region in 2020
Figure 63. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue Market Share by Region in 2020
Figure 64. China CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 65. China CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 67. Japan CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 69. South Korea CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 71. India CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 73. Australia CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. China Taiwan CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 75. China Taiwan CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 77. Indonesia CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 79. Thailand CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 81. Malaysia CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Latin America CD38 Monoclonal Antibody Drugs Sales Growth Rate 2016-2021 (KG)
Figure 83. Latin America CD38 Monoclonal Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 84. Latin America CD38 Monoclonal Antibody Drugs Sales Market Share by Country in 2020
Figure 85. Latin America CD38 Monoclonal Antibody Drugs Revenue Market Share by Country in 2020
Figure 86. Mexico CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 87. Mexico CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Brazil CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 89. Brazil CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Argentina CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 91. Argentina CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales Growth Rate 2016-2021 (KG)
Figure 93. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 94. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales Market Share by Country in 2020
Figure 95. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue Market Share by Country in 2020
Figure 96. Turkey CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 97. Turkey CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Saudi Arabia CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 99. Saudi Arabia CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. UAE CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 101. UAE CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. CD38 Monoclonal Antibody Drugs Value Chain
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed
Keyplayers in Global and China CD38 Monoclonal Antibody Drugs Market Insights, Forecast to 2027
JohnsonSanofi
Takeda Pharmaceutical Company
CASI Pharmaceutical Company
Mab Biopharma